Biomarker-estimated Flavanol Intake in Davis (FID)

(FID Trial)

Overseen By Jodi L Ensunsa, MS

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of California, Davis

Disqualifiers: Substance abuse, GI cancer, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 2

200 Participants Needed

Trial Summary

What is the purpose of this trial?

This trial collects urine samples from people in the US to study how much of certain beneficial plant compounds they consume and how their bodies process these compounds. Researchers use specific indicators in the urine to measure this intake accurately.

Research Team

Francene M. Steinberg, PhD, RD

Principal Investigator

University of California, Davis

Eligibility Criteria

Inclusion Criteria

You are between 25 and 75 years of age.

Are you male or female?

Your body mass index (BMI) is between 18.5 and 34.9 kg/m2.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Baseline Assessment

Initial assessment of biomarker-estimated (-)-epicatechin and flavanol intake through urine samples and other health metrics

1 day

1 visit (in-person)

Data Collection

Collection of urine samples to assess biomarker-estimated flavanol intake and other health metrics

1 day

1 visit (in-person)

Follow-up

Participants are monitored for any changes in biomarker-estimated flavanol intake and health metrics

1-2 weeks

Treatment Details

Participant Groups

Group I: Adults in Davis and the greater Sacramento area of California Experimental Treatment 1 Intervention

Adults in Davis and the greater Sacramento area of California

Who Is Running the Clinical Trial?

University of California, Davis

Lead Sponsor

Trials

958

Recruited

4,816,000+

Mars, Inc.

Industry Sponsor

Trials

20

Recruited

26,500+